Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells

Trial Profile

Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Autologous muscle-derived stem cell therapy Cook MyoSite (Primary)
  • Indications Urinary incontinence
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Cook MyoSite
  • Most Recent Events

    • 02 Feb 2017 Status changed from recruiting to active, no longer recruiting.
    • 20 Jan 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 18 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top